biotech92
Oct 16, 5:16 PM
$FLYE Yikes, this one is in worse shape than
$POLA and
$FLUX: • Severe Cash Burn & Microscopic Reserves: As of recent financial reviews, the company was burning roughly
$1.15 million per month in operating cash flow, while holding less than
$300,000 in liquid cash reserves. Because the business is bleeding heavy cash, equity issuance (selling new stock) is one of its only pathways to stay afloat.
• Massive Historical Dilution: This is not just a future concern; it is actively happening. Shareholders have already been substantially diluted, with the company's shares outstanding increasing by over 119% in the past year and up over 345% over a two-year lookback.
• Deeply Negative Profit Margins: With an annual revenue of
$19.1 million but a profit margin sitting around -49% to -68%, the core business operations lose money on every unit shipped. It cannot fund itself via organic cash flow.
• Regulatory and Listing Headwinds: The company has faced major corporate hurdles, including
1 replies